Publications by authors named "Cecilia Michel"
Ther Adv Chronic Dis
January 2024
Article Synopsis
- The development of biosimilars like AVT02, a version of Humira, involves extensive comparisons to the original product, ensuring no significant clinical differences exist regarding structure and function.
- AVT02 showed high structural similarity to Humira through various scientific methods, with minimal differences that didn’t affect its biological activity or safety.
- Clinical studies confirmed that AVT02 matched Humira in pharmacokinetics and safety profiles, supporting its approval for all global indications where Humira is used.
